(Q46934279)

English

Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.

scientific article published in March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B. (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

Aspergillus fumigatus

0 references

Candida albicans

1 reference

based on heuristic

inferred from title

Aspergillus terreus

object named as

Aspergillus terreus

1 reference

based on heuristic

inferred from title

Aspergillus nidulans

object named as

Aspergillus nidulans

1 reference

based on heuristic

inferred from title

author name string

Jagpal Singh

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

Dagmar Rimek

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

Reinhard Kappe

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

publication date

1 March 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

49

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

96-103

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Aspergillus nidulans is frequently resistant to amphotericin B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Antifungal drug resistance to azoles and polyenes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Candida lusitaniae infections in the era of fluconazole availability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Aspergillus nidulans Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01197.X

21 January 2018

Identifiers

10.1111/J.1439-0507.2006.01197.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16466441

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46934279&oldid=1733259828"